Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis

NCT01613898 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT01613898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01613898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
June 30, 2015
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrotendinous xanthomatosis (ctx)